“Very efficient and courteous staff. Dr. is thorough, helpful, explained clearly, answered questions. Appointment soon as new patient. Will see him annually.”
Nonproliferative Diabetic Retinopathy: What You Need to Know
Who Is at Risk
Diabetic retinopathy is one of the most common complications of diabetes, and several factors influence when and how severely it develops. Knowing your personal risk factors helps you and your care team take the most effective preventive steps.
Diabetic retinopathy affects roughly one in four people living with diabetes in the United States. It accounts for more cases of vision impairment than age-related macular degeneration and glaucoma combined. This makes it one of the leading causes of preventable vision loss in working-age adults.
The length of time a person has lived with diabetes is one of the strongest predictors of developing NPDR. Research has shown that retinal changes are present in roughly a quarter of patients within five years of diagnosis, in about sixty percent at ten years, and in approximately eighty percent at fifteen years. The longer blood sugar remains elevated, the more cumulative damage occurs to retinal blood vessels. Maintaining blood glucose levels as close to your target range as possible is among the most effective ways to slow or prevent NPDR from developing or worsening.
High blood pressure (hypertension) places added stress on already weakened retinal vessels and is a major contributor to NPDR progression. Elevated triglyceride levels, higher body mass index, and smoking are also linked to greater risk. These are all factors you and your primary care physician or endocrinologist can actively address. Patients who have diabetic peripheral neuropathy (nerve damage in the hands and feet) often share the same underlying vascular risk factors and may be more likely to have advanced retinal changes as well.
Both type 1 and type 2 diabetes can lead to diabetic retinopathy. Younger patients with type 1 diabetes can develop significant retinal damage, particularly if blood sugar control has been difficult to maintain over many years. Age is also a factor because older adults have generally lived with diabetes longer. Regardless of type or age, regular retinal monitoring is essential for everyone with diabetes.
Symptoms and Warning Signs
NPDR is often called a 'silent' condition because it frequently causes no pain or noticeable vision changes in its early stages. Knowing when the disease is likely to be asymptomatic and when to seek urgent attention can make a critical difference.
In mild and moderate NPDR, the retinal changes occur at a microscopic level that cannot be detected without specialized equipment. Most people see normally and feel no discomfort, even while significant damage is accumulating. This is the primary reason that annual dilated eye exams are so important for everyone with diabetes. By the time vision changes become noticeable, the disease may have already advanced to a more serious stage.
If NPDR does affect vision, it is most often because of diabetic macular edema (DME), which occurs when fluid leaks into the macula, the central part of the retina responsible for sharp detail vision. DME can cause blurred or distorted central vision and difficulty with tasks like reading or recognizing faces. Colors may also appear faded or washed out. These changes typically develop gradually rather than suddenly.
Some symptoms suggest that diabetic retinopathy may have progressed to a more serious stage and require urgent assessment. Do not wait for your next scheduled visit if you experience any of the following.
- A sudden increase in floaters (spots, strings, or specks drifting through your vision)
- Flashes of light in one or both eyes
- A shadow, curtain, or dark area appearing across part of your visual field
- Sudden loss of vision in one eye
These symptoms may indicate a retinal tear, retinal detachment, or hemorrhage into the vitreous. Seek evaluation from a retina specialist or go to an emergency room right away.
How NPDR Is Diagnosed
Accurate diagnosis of NPDR depends on a combination of clinical examination and advanced imaging. Our team uses a full range of diagnostic tools to detect disease, measure severity, and track changes over time.
The dilated eye exam is the cornerstone of NPDR detection. Drops are placed in the eyes to widen the pupils, allowing the retina specialist to view the retina directly with specialized lenses. This exam identifies the hallmark findings of NPDR, including microaneurysms, hemorrhages, hard exudates, and cotton-wool spots. It also provides the most complete assessment of the peripheral retina, where some early changes first appear.
Optical coherence tomography (OCT) is a noninvasive, painless scan that produces detailed cross-sectional images of the retina. OCT can detect very small amounts of fluid within or beneath the retinal layers, measure retinal thickness precisely, and identify the earliest signs of macular edema before it affects vision. It is one of the most valuable tools for monitoring NPDR over time. OCT angiography, a related technique, can also map blood flow within the retinal vessels without the need for a dye injection.
Fluorescein angiography involves injecting a harmless dye into a vein in the arm. As the dye travels through the retinal blood vessels, a rapid series of photographs is taken. These images reveal areas of leakage, reduced blood flow (ischemia), and microaneurysms in detail. This test is particularly helpful for determining the severity of NPDR and identifying patients who may benefit from treatment.
Wide-field retinal photography captures a large portion of the retina in a single image, including areas of the peripheral retina that earlier technologies could not easily reach. Serial photography, meaning comparison of images taken at each visit over time, allows your retina specialist to track whether NPDR is stable, improving, or progressing. This type of ongoing visual documentation is central to how we monitor our patients at every appointment.
Treatment and Management
Treatment for NPDR depends on the stage of disease, whether macular edema is present, and how well systemic risk factors are controlled. Your retina specialist will individualize the approach based on your specific situation.
For many patients with mild to moderate NPDR, the primary strategy is careful monitoring combined with tight control of blood sugar, blood pressure, and cholesterol. This approach is supported by long-standing research in diabetic eye disease. Working closely with your primary care physician or endocrinologist to reach and maintain recommended targets is one of the most powerful ways to preserve vision.
- Keep hemoglobin A1c as close to your target level as your physician recommends
- Control blood pressure to reduce stress on retinal blood vessels
- Manage cholesterol and triglyceride levels
- Avoid smoking
- Maintain a healthy body weight and stay physically active
Anti-VEGF medications block a protein called vascular endothelial growth factor (VEGF), which drives abnormal blood vessel leakage and growth. These medications are delivered as intravitreal injections, meaning they are injected directly into the vitreous cavity of the eye using a very fine needle. Anti-VEGF agents including Avastin (bevacizumab), Lucentis (ranibizumab), Eylea (aflibercept), and Vabysmo (faricimab) are used to treat diabetic retinopathy and DME. Clinical trials have shown that anti-VEGF treatment can improve diabetic retinopathy severity scores and reduce the risk of progression in eyes with moderately severe to severe NPDR. Your retina specialist will weigh the severity of your NPDR, the presence or absence of macular edema, and your overall health when deciding whether injections are appropriate.
Large clinical trials, including Protocol W, confirmed that early anti-VEGF treatment for NPDR can improve disease severity scores and reduce vision-threatening complications. However, four-year results from Protocol W also showed that early treatment did not provide a long-term visual acuity advantage over careful observation in patients who did not yet have center-involving macular edema. For many patients with NPDR and no current DME, watchful monitoring may remain the preferred approach. The decision to begin injections is always individualized and based on a thorough review of your retinal findings.
Scatter laser photocoagulation, also called panretinal photocoagulation (PRP), uses precisely focused laser energy to treat areas of the retina with poor blood flow. While PRP is most commonly used for proliferative diabetic retinopathy, selected cases of severe NPDR may also benefit from this treatment. Laser photocoagulation does not restore lost vision; its goal is to reduce the risk of further progression. Your retina specialist will discuss whether laser treatment is appropriate based on the extent of your retinal disease.
Fenofibrate is a medication typically used to lower triglyceride levels. Research has suggested it may also help slow the progression of diabetic retinopathy, with the most pronounced benefit seen in patients with milder disease at the start of treatment. Whether fenofibrate is appropriate for you is a conversation to have with your retina specialist and your primary care physician, as it depends on your full medical history and current medications.
Monitoring and Follow-Up
NPDR is a condition that requires ongoing, structured monitoring. The frequency of follow-up depends on the severity of disease and how well risk factors are managed, and it may change over time as your condition evolves.
Patients with mild NPDR are typically recommended for follow-up every six to twelve months. Moderate NPDR usually warrants visits every three to six months. Severe NPDR may require follow-up every two to four months given the higher risk of rapid progression. These intervals are guidelines, and your retina specialist may adjust your schedule based on new findings or changes in your systemic health.
At each follow-up appointment, your retina specialist will perform a dilated exam and typically obtain OCT imaging to assess the macula for fluid. You may be asked about any changes in your vision, your most recent blood sugar readings, and any updates to your medications. Serial retinal photographs are compared to previous images to identify subtle progression that might not yet affect your vision. This careful, longitudinal approach allows treatment to be started promptly if and when it becomes necessary.
All people with diabetes should have a comprehensive dilated eye exam at least once a year. For type 1 diabetes, the first exam is recommended within five years of diagnosis. For type 2 diabetes, screening should begin at the time of diagnosis. Women with diabetes who become pregnant should have an eye exam early in the first trimester, as pregnancy can accelerate retinal changes. Meeting these screening timelines gives your care team the best opportunity to catch NPDR early, when intervention is most effective.
Living Well With NPDR
A diagnosis of NPDR does not mean vision loss is inevitable. With the right management, many people with NPDR maintain good vision for years. Understanding what you can do in daily life to support your retinal health is an important part of long-term care.
Consistent control of blood sugar, blood pressure, and cholesterol remains the single most impactful thing you can do to protect your retinal health. Working with your primary care physician or endocrinologist to set and maintain appropriate targets gives your retinal blood vessels the best chance to remain stable. Even incremental improvements in these numbers can meaningfully slow the progression of NPDR over time.
Regular physical activity, a balanced and nutritious diet, maintaining a healthy weight, and not smoking all contribute to better blood vessel health throughout the body, including in the retina. These are not passive suggestions. Each of these factors has a direct effect on the microvascular damage that drives NPDR. Modest, consistent improvements in lifestyle can compound positively over months and years.
It is natural to feel anxious or uncertain after receiving a diagnosis that involves your eyesight. Many people find it helpful to know that mild and moderate NPDR often remain stable for years when well managed. Staying informed, keeping all scheduled appointments, and following your treatment plan are the most reliable ways to stay in control of the condition. If you notice any vision changes between appointments, reach out to your retina specialist promptly rather than waiting for your next scheduled visit.
Frequently Asked Questions
These answers are meant to address questions that commonly come up after an NPDR diagnosis, with practical guidance to help you make informed decisions about your care.
Yes, in some cases. Clinical trials have shown that anti-VEGF treatment can reduce the severity score of NPDR on standardized grading scales, meaning that some of the visible retinal abnormalities can diminish. However, this improvement in grading is not the same as a complete reversal of all underlying damage to the retinal vessels. The most durable gains come from sustained control of blood sugar, blood pressure, and other systemic risk factors, which slow the rate of new damage from forming in the first place.
Not necessarily. Many patients with mild to moderate NPDR and no macular edema are managed with observation and systemic health control rather than injections. Long-term trial data has shown that beginning anti-VEGF injections before center-involving macular edema develops does not provide a clear visual acuity benefit for most patients in that category. Your retina specialist will assess the full picture, including the severity of your retinal findings, whether any fluid is present in the macula, and how stable your diabetes control has been, before recommending a treatment path.
Progression rates vary considerably from person to person. Patients with mild NPDR who maintain careful blood sugar and blood pressure control may remain stable for many years without advancing to PDR. Patients with severe NPDR, on the other hand, carry a meaningfully elevated risk of progressing to PDR within one year, which is why close monitoring at that stage is so important. Your specific risk depends on the severity of your current NPDR, how long you have had diabetes, and how consistently your risk factors are managed.
In most cases, regular physical activity is encouraged for people with diabetes and NPDR because it supports blood sugar control and cardiovascular health. However, patients with severe NPDR should discuss exercise intensity with their retina specialist before engaging in strenuous or high-impact activities, as certain types of exertion can theoretically stress fragile retinal vessels. Your retina specialist can provide guidance specific to your stage of disease and your overall health status.
Unlike age-related macular degeneration, for which specific AREDS-based supplements have well-established evidence, there is currently no supplement with strong clinical proof of preventing or treating diabetic retinopathy. Some research has explored antioxidants and omega-3 fatty acids, but the results have not been conclusive enough to form a standard recommendation. The most reliable protection for your retina remains consistent blood sugar and blood pressure control paired with regular retinal monitoring.
NPDR describes the overall stage of diabetic damage to retinal blood vessels, while diabetic macular edema (DME) is a specific complication that can occur at any stage of NPDR. DME develops when leaking fluid accumulates in the macula, the central zone responsible for sharp vision, causing swelling that blurs or distorts central vision. A patient can have NPDR without DME, and treatment decisions depend heavily on whether DME is also present. If DME involves the center of the macula, your retina specialist will typically recommend treatment sooner rather than later.
Visit Atlantic Retina Center
Atlantic Retina Center is a single-specialty practice devoted entirely to the retina, vitreous, and macula, with clinic locations throughout the Eastern Shore of Maryland and central and southern Delaware. Our fellowship-trained, board-certified team uses advanced imaging and proven treatments to detect and manage nonproliferative diabetic retinopathy at every stage. If you have diabetes and have not had a dilated retinal exam recently, we encourage you to schedule an appointment so we can help protect the vision you depend on.